(Q42809444)

English

Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression

scientific article published on October 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Trichostatin A-histone deacetylase inhibitor with clinical therapeutic potential-is also a selective and potent inhibitor of gelatinase A expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

author name string

Menachem Ailenberg

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Mel Silverman

2

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

language of work or name

0 references

publication date

1 October 2002

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Biochemical and Biophysical Research Communications

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

298

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

110-115

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Acetylation and chromosomal functions.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Specificity of gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Roles of histone acetyltransferases and deacetylases in gene regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Histone acetylation and transcriptional regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Chromatin remodeling enzymes: who's on first?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Code of silence

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Transcription. Unlocking the gates to gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Cooperation between complexes that regulate chromatin structure and transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Chromatin disruption and modification

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Gene activation by histone and factor acetyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Histone acetylation and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Transient vs. prolonged histone hyperacetylation: effects on colon cancer cell growth, differentiation, and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Matrix metalloproteinases: they're not just for matrix anymore!

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Regulation of matrix metalloproteinase expression in tumor invasion.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Histone acetylation in chromatin structure and transcription

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Cellular activation of mesangial gelatinase A by cytochalasin D is accompanied by enhanced mRNA expression of both gelatinase A and its membrane-associated gelatinase A activator (MT-MMP).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

The novel anti-tumour agent oxamflatin differentially regulates urokinase and plasminogen activator inhibitor type 2 expression and inhibits urokinase-mediated proteolytic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Regression of hypertrophied rat pulmonary arteries in organ culture is associated with suppression of proteolytic activity, inhibition of tenascin-C, and smooth muscle cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2902420-8

7 January 2021

Identifiers

10.1016/S0006-291X(02)02420-8

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42809444&oldid=2050223652"